This message was sent to ##Email##
|
|
|
|
|
AST
The ATC 2020 Virtual Congress is set to launch May 30, 2020! This year's event will deliver an all-new, OnDemand virtual experience that will bring together professionals working in all aspects of solid organ and tissue transplantation to hear the newest research, connect across disciplines, and advance the specialty.
Attendees can earn up to 149.5 CME, ACPE, ANCC, CEPTC Credit/Contact hours and will have over 1 year of OnDemand session access.
READ MORE
AST
With the growing concern about the Coronavirus (COVID-19), the AST has published FAQ pages and other resources for both professionals and patients. Check out a full list of COVID-19 resources here.
READ MORE
AST
The AST's Infectious Disease Community of Practice has received queries from
transplant and donation colleagues regarding the novel coronavirus (2019-nCoV). These
FAQs were developed with input of members from both the organ donation
and transplantation communities to relay information on the current state of knowledge.
Check our website frequently, as these resources are being updated regularly.
READ MORE
AST
Information regarding COVID-19 is changing rapidly. This document will be updated with the evolving issues related to medication access and drug shortages/supply chain issues within the United States of America during the pandemic.
 |
|
Promoted by
Veloxis Pharmaceuticals
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
Watch Video
|
|
AST
In the interest of facilitating patient care and advancing science, and ensuring that accurate knowledge and experience is available to all during this current time of crisis, AJT has been expediting review of all papers dealing with COVID-19, as well as making them free to access for all.
READ MORE
 |
|
RELiZORB mimics the function of pancreatic lipase and delivers absorbable fats to your patients.
Indicated for use in pediatric patients (ages 5 years and above) and adult patients to hydrolyze fats in enteral formula.
Learn more at relizorb.com REL20-310
|
|
AST
The AST recently created a position statement opposing the "Bringing Enhanced Treatments and
Therapies to End Stage Renal Disease (ESRD) Recipients (BETTER) Kidney Care Act."
READ MORE
Veloxis Pharmaceuticals
 Explore this phase 3 randomized, double-blind, double-dummy, multicenter, multinational, non-inferiority trial published in the American Journal of Transplantation. The study examined treatment failures defined as BPAR, graft failure, death, and delayed graft
function at 3 months and 12 months.
READ MORE
AST
The AST Board of Directors election is now open. If you are an eligible member of the AST, check your email for information on how to vote. More information about the nominees can be found here.
|
|
AST
We encourage all members to attend our virtual Town Hall, which will be held Monday, June 1, 2020, at 4:30 pm ET. During the Town Hall, we will announce the results of our 2020 Board of Directors election, honor and recognize AST members, and discuss topics that impact the community-at-large.
The Town Hall will be held during the 2020 American Transplant Congress meeting. Information on how to access the Town Hall will be available on our website.
AST
The AST is pleased to announce the results of the 2020 Communities of Practice (COP) Executive Committee (EC) elections, which include the Co-Chairs, Members-at-Large, and Early Career Members-at-Large.
More information on the 2020-2021 Executive Committees and members rotating off their current roles can be found on our website.
READ MORE
AST
CareDx, Inc., in collaboration with the AST Research Network, is seeking proposals for "Utility of Donor Derived Cell Free DNA."
The submission deadline has been extended to June 19, 2020, to support the needs of transplant professionals during the COVID-19 pandemic. The start of the grant term will remain October 1, 2020.
READ MORE
|
The Path Beyond COVID-19
Management of Kidney Transplant Patients Using TruGraf for Surveillance. May 31 from 1:10pm - 2:10pm EDT. To view the agenda and register, visit:
https://bit.ly/2T0irqP
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
AST
The Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act would extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients, which is currently limited to just 36 months. Please take a moment to contact your Members of Congress about this important legislation. Contact Congress Today
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
|
Promoted by
|
|
|
|
 |
| Upcoming Education Events
|
    |
AST
HCV NAT+/- in Abdominal Organ Transplantation: Where Are We Now and What's Next?
May 27, 2020 | 2 pm ET | Online Activity
For more information, click here.
"New French heart allocation system: comparison with Eurotransplant and United States allocation systems"
June 9, 2020 | 2 pm ET | Online Activity
For more information, click here.
American Journal of Transplantation
This Meeting Report from the XVth Banff conference describes the creation of a multi‐organ transplant gene panel by the Banff Molecular Diagnostics Working Group (MDWG). This Banff Human Organ Transplant (B‐HOT) panel is the culmination of previous work by the MDWG to identify a broadly useful gene panel based on whole transcriptome technology.
READ MORE
The Journal of Heart and Lung Transplantation
The demand for donated human hearts far exceeds the number available. Xenotransplantation of genetically modified porcine organs provides an alternative. In 2000, an Advisory Board of the International Society for Heart and Lung Transplantation (ISHLT) set the benchmark for commencing clinical cardiac xenotransplantation as consistent 60% survival of non-human primates after life-supporting porcine heart transplantations.
READ MORE
|
|
American Journal of Transplantation
Solid organ transplant (SOT) recipients who are cytomegalovirus (CMV) seronegative (R‐) and receive seronegative donor (D‐) organs have a small but currently unquantified risk of both transfusion‐transmitted CMV (TT‐CMV) and community‐acquired CMV (CA‐CMV).
READ MORE
Clinical Journal of American Society of Nephrology
The global pandemic of coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2, continues to spread, with cases now reported in almost every country in the world. As the burden of disease grows, there is increased emphasis on understanding disease presentation and management in high-risk subgroups. One such group is kidney transplant recipients, who many have suspected to have an increased risk of severe disease due to their underlying immunosuppression and a high prevalence of other comorbidities associated with the development of severe disease, such as hypertension, diabetes, cardiovascular disease, and CKD.
READ MORE
The Journal of Heart and Lung Transplantation
Gastroesophageal reflux disease (GERD) is a risk factor for chronic lung allograft dysfunction (CLAD). The presence of bile acids—putative markers of gastric microaspiration—and inflammatory proteins in the bronchoalveolar lavage (BAL) has been associated with CLAD, but their relationship with GERD remains unclear. While GERD is thought to drive chronic microaspiration, selection of patients for anti-reflux surgery lacks precision. This multicenter study aimed to test the association of BAL bile acids with GERD, lung inflammation, allograft function, and anti-reflux surgery.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
